Review on Bilayer Tablets

Bi-layer tablets are essential for developing both immediate and modified drug delivery systems for various diseases. They facilitate controlled medication release, representing a significant advancement in Controlled Drug Delivery Systems (CDDS) and improving the effectiveness of medication delivery. Over the past 30 years, the complexity and costs of introducing new drugs have increased, leading to greater focus on sustained or controlled release systems. Bi-layer tablets enable precise delivery of medications with predetermined release profiles, preventing chemical incompatibilities between Active Pharmaceutical Ingredients (APIs). This technology supports combination therapies for conditions like hypertension, diabetes, and pain relief. Many pharmaceutical companies are investing in bi-layer tablet development for advantages such as patent extension and marketing opportunities. This review discusses bi-layer tablet technology, manufacturing challenges, the types of tablet presses used, and the relevant quality and Good Manufacturing Practice (GMP) standards. Additionally, it covers recent advancements in the field.[3].

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-03-13
DOI
https://doi.org/10.5281/zenodo.15019243
Primary Topic
Speech Recognition and Synthesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Review on Bilayer Tablets

Zenodo (CERN European Organization for Nuclear Research)
Speech Recognition and Synthesis
article

Review on Bilayer Tablets

article en

Abstract

Bi-layer tablets are essential for developing both immediate and modified drug delivery systems for various diseases. They facilitate controlled medication release, representing a significant advancement in Controlled Drug Delivery Systems (CDDS) and improving the effectiveness of medication delivery. Over the past 30 years, the complexity and costs of introducing new drugs have increased, leading to greater focus on sustained or controlled release systems. Bi-layer tablets enable precise delivery of medications with predetermined release profiles, preventing chemical incompatibilities between Active Pharmaceutical Ingredients (APIs). This technology supports combination therapies for conditions like hypertension, diabetes, and pain relief. Many pharmaceutical companies are investing in bi-layer tablet development for advantages such as patent extension and marketing opportunities. This review discusses bi-layer tablet technology, manufacturing challenges, the types of tablet presses used, and the relevant quality and Good Manufacturing Practice (GMP) standards. Additionally, it covers recent advancements in the field.[3].

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 75%
Speech Recognition and Synthesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.